Skip to main content
. 2022 Nov 30;20(4):592–599. doi: 10.9758/cpn.2022.20.4.592

Table 1.

PICOS criteria for study selection

Parameter Inclusion Exclusion
Patients Diagnosis of schizophrenia according to the ICD/DSM criteria, any version Age ≥ 18 years
Intervention Olanzapine monotherapy, any dose
Comparator Placebo or other pharmacological treatments
Outcomes Effect on the anxiety-related symptoms (measured by scores from clinical scales) Absence of measurements concerning the anxiety dimension
Study design double blind (db) RCT; post hoc analyses of dbRCTs

PICOS, Population, Intervention, Comparison, Outcomes and Study; ICD, International Classfication of Diseases; DSM, Diagnostic and Statistical Manual of Mental Disorders; RCT, randomized controlled trial.